Pluristem Therapeutics To Collaborate With Israel In Treatment Of Burn Injuries

Pluristem Therapeutics Inc. (PSTI) announced the receipt of a joint grant awarded by the Israeli Ministry of Defense and the Israel Innovation Authority for the development of the company's PLX cells for the treatment of burn injuries.

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

MARLBOROUGH, Mass., April 23, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Dru

AbbVie Receives European Commission Approval of VENCLYXTO® (venetoclax) Plus Rituximab for...

NORTH CHICAGO, Ill., Nov. 1, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that th

AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential...

NORTH CHICAGO, Ill. and CAMBRIDGE, Mass., Feb. 20, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Voyager Therapeutics, Inc

‘ phase III QUARTZ study of new investigational inhaled combination treatment...

Novartis' phase III QUARTZ study of new investigational inhaled combination treatment QMF149 meets primary and key secondary endpoints in patients with inadequately controlled asthma Source:...

Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global...

Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer hea

Dr Reddys Laboratories launches Tadalafil Tablets USP in US market |...

Read more about Dr Reddys Laboratories launches Tadalafil Tablets USP in US market on Business Standard. The Cialis brand and generic had U.S. sales of approximately $1.7 billion MAT for the most recent twelve months ending in January 2019 according to IMS Health.

Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two...

DARMSTADT, Germany, January 24, 2019 /PRNewswire/ -- Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editin

Plaque Psoriasis Armamentarium Gets New Addition | Markets Insider

(RTTNews) - The therapeutic armamentarium for plaque psoriasis patients is fairly well-stocked, and now there is one more addition to it.The FDA ha

GMOs Are Safe, Says Us Biotech Expert

Biggest News Source for News in Uganda and the East African Region ,Breaking news in Uganda and Daily news and the latest from Uganda